| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 4441- | SeNPs, | The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures |
| - | Review, | Nor, | NA |
| 4470- | SeNPs, | Chit, | Synthesis and cytotoxic activities of selenium nanoparticles incorporated nano-chitosan |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF7 |
| 4467- | SeNPs, | VitC, | Chit, | Nano-chitosan-coated, green-synthesized selenium nanoparticles as a novel antifungal agent against Sclerotinia sclerotiorum in vitro study |
| - | Study, | Nor, | NA |
| 4465- | SeNPs, | VitC, | Selenium nanoparticles: Synthesis, in-vitro cytotoxicity, antioxidant activity and interaction studies with ct-DNA and HSA, HHb and Cyt c serum proteins |
| - | Study, | Var, | NA |
| 4463- | SeNPs, | VitC, | Selenium nanoparticles: Synthesis, characterization and study of their cytotoxicity, antioxidant and antibacterial activity |
| - | Study, | Nor, | NA |
| 4461- | SeNPs, | VitC, | Synthesis, Characterization, and Cytotoxic Evaluation of Selenium Nanoparticles |
| - | Study, | Var, | NA |
| 4446- | SeNPs, | Antioxidant and Hepatoprotective Effects of Moringa oleifera-mediated Selenium Nanoparticles in Diabetic Rats. |
| - | in-vivo, | Diabetic, | NA |
| 4457- | SeNPs, | Selenium nanoparticles: a review on synthesis and biomedical applications |
| - | Review, | Var, | NA | - | NA, | Diabetic, | NA |
| 4458- | SeNPs, | Selenium Nanoparticles for Antioxidant Activity and Selenium Enrichment in Plants |
| - | Study, | Nor, | NA |
| 4459- | SeNPs, | VitC, | SSE, | Nano and mesosized selenium and its synthesis using the ascorbic acid route |
| - | Study, | Var, | NA |
| 4460- | SeNPs, | VitC, | Ascorbic acid-mediated selenium nanoparticles as potential antihyperuricemic, antioxidant, anticoagulant, and thrombolytic agents |
| - | Study, | Var, | NA |
| 4462- | SeNPs, | VitC, | Selenium nanoparticles: influence of reducing agents on particle stability and antibacterial activity at biogenic concentrations |
| - | Study, | Nor, | NA |
| 9277- | SES, SSM, | Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma |
| - | vitro+vivo, | Gall, | SGC996 |
| 9238- | SFN, | Effect of meal composition and cooking duration on the fate of sulforaphane following consumption of broccoli by healthy human subjects |
| - | Trial, | Nor, | NA |
| 8778- | SFN, | Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| - | in-vitro, | Pca, | NA |
| 2406- | SFN, | Sulforaphane and Its Protective Role in Prostate Cancer: A Mechanistic Approach |
| - | Review, | Pca, | NA |
| 2448- | SFN, | Sulforaphane and bladder cancer: a potential novel antitumor compound |
| - | Review, | Bladder, | NA |
| 2554- | SFN, | Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm |
| - | Review, | Var, | NA |
| 2552- | SFN, | Chemo, | Chemopreventive activity of sulforaphane |
| - | Review, | Var, | NA |
| 1507- | SFN, | Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects |
| - | in-vivo, | Colon, | NA | - | Human, | Nor, | NA |
| 1501- | SFN, | The Inhibitory Effect of Sulforaphane on Bladder Cancer Cell Depends on GSH Depletion-Induced by Nrf2 Translocation |
| - | in-vitro, | CRC, | T24/HTB-9 |
| 1725- | SFN, | Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway |
| - | Review, | Var, | NA |
| 1726- | SFN, | Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential |
| - | Review, | Var, | NA |
| 3305- | SIL, | Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vivo, | NA, | NA |
| 3309- | SIL, | Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives |
| - | Review, | Nor, | NA |
| 3314- | SIL, | Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review |
| - | Review, | Nor, | NA |
| 3293- | SIL, | Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer |
| - | Review, | Var, | NA |
| 3282- | SIL, | Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions |
| - | Review, | Var, | NA |
| 3321- | SIL, | Silymarin (Milk thistle) |
| - | Review, | AD, | NA |
| 2306- | SIL, | CUR, | RES, | EA, | Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment |
| - | in-vitro, | BC, | MDA-MB-231 |
| 4128- | Silicon, | Silicon as Versatile Player in Plant and Human Biology: Overlooked and Poorly Understood |
| - | Review, | Nor, | NA |
| 4133- | Silicon, | Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study |
| - | Study, | AD, | NA |
| 2361- | SK, | Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer |
| - | in-vivo, | CRC, | NA |
| 2218- | SK, | Shikonin Alleviates Endothelial Cell Injury Induced by ox-LDL via AMPK/Nrf2/HO-1 Signaling Pathway |
| - | in-vitro, | Nor, | HUVECs |
| 2007- | SK, | Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells |
| - | in-vitro, | lymphoma, | U937 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | SkBr3 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | OS, | U2OS | - | NA, | Nor, | RPE-1 |
| 9033- | SP, | Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential |
| - | Review, | Var, | NA |
| 9043- | SP, | Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis |
| - | in-vivo, | HCC, | NA |
| - | Trial, | Colon, | NA |
| 9035- | SP, | Evaluation of chemoprevention of oral cancer with Spirulina fusiformis |
| - | Trial, | Oral, | NA |
| 9036- | SP, | The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors |
| - | Trial, | Var, | NA |
| 9039- | SP, | Comparative evaluation of spirulina and lycopene as an adjuvant to intralesional corticosteroid injection therapy in the management of oral submucous fibrosis: A pilot study |
| - | Trial, | Nor, | NA |
| 9040- | SP, | Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial |
| - | Trial, | Covid, | NA |
| 9041- | SP, | Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial |
| - | Trial, | Col, | NA |
| 9038- | SP, | The Efficacy of Spirulina on Cognitive Function, Psychological and Clinical Indicators in Men Patients Under Methadone Therapy (a Randomized Trial) |
| - | Trial, | Nor, | NA |
| 4895- | Sper, | Spermidine as a target for cancer therapy |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5789- | Sper, | Long-term oral polyamine intake increases blood polyamine concentrations |
| - | Human, | Nor, | NA |
| 5805- | Sper, | The Effect of Spermidine Supplementation on Cognitive Function in Adults: A Mini-Review |
| - | Review, | AD, | NA |
| 5799- | Sper, | The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial |
| - | Trial, | AD, | NA |
| 1688- | SSE, | Potential Role of Selenium in the Treatment of Cancer and Viral Infections |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid